Atlas Trials

Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo

Clinical trial NCT05354076 · UNKNOWN

Trial details

NCT number
NCT05354076
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Malignant Tumors
Start date
2000-03-01
Primary completion
2022-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.